Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Frontiers in Pharmacology|November 15, 2023
Implementing competing risks in discrete event simulation: the event-specific probabilities and distributions approachFanny Franchini, Victor Fedyashov, Maarten J IJzerman, et al.
Nature Reviews. Immunology|September 12, 2015
Emerging cytokine networks in colorectal cancerNathan R West, Sarah McCuaig, Fanny Franchini, et al.
British Journal of Cancer|November 3, 2024
Cancer and treatment specific incidence rates of immune-related adverse events induced by immune checkpoint inhibitors: a systematic reviewBishma Jayathilaka, Farah Mian, Fanny Franchini, et al.
European Journal of Cancer (Oxford, England : 1990)|December 13, 2025
Current and emerging opportunities for deintensification of systemic therapies in melanoma: A scoping reviewJennifer A Soon, Fanny Franchini, Peter Gourlay, et al.
Critical Reviews in Oncology/Hematology|December 20, 2024
Analysis of risk factors for immune-related adverse events induced by immune checkpoint inhibitor treatment in cancer: A comprehensive systematic reviewBishma Jayathilaka, Farah Mian, Jo Cockwill, et al.
JTO Clinical and Research Reports|August 19, 2024
Real-World Treatment and Outcomes in ALK-Rearranged NSCLC: Results From a Large U.S.-Based DatabaseGrace Chazan, Fanny Franchini, Roma Shah, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 8, 2024
Predicting the Population Health Economic Impact of Current and New Cancer Treatments for Colorectal Cancer: A Data-Driven Whole Disease Simulation Model for Predicting the Number of Patients with Colorectal Cancer by Stage and Treatment Line in AustraliaKoen Degeling, Yat Hang To, Karen Trapani, et al.
Scientific Reports|November 28, 2022
A scoping review and meta-analysis on the prevalence of pan-tumour biomarkers (dMMR, MSI, high TMB) in different solid tumoursYoon-Jung Kang, Sophie O'Haire, Fanny Franchini, et al.
Scientific Reports|March 14, 2023
Systematic review of NTRK 1/2/3 fusion prevalence pan-cancer and across solid tumoursSophie O'Haire, Fanny Franchini, Yoon-Jung Kang, et al.
Lung Cancer (Amsterdam, Netherlands)|July 4, 2020
Real world outcomes in KRAS G12C mutation positive non-small cell lung cancerWanyuan Cui, Fanny Franchini, Marliese Alexander, et al.
Pageof 3